Results 71 to 80 of about 19,146 (219)

Detrusor overactivity successfully treated with duloxetine

Journal of Obstetrics and Gynaecology, 2007
A 47-year-old patient G3P3 was referred to the urogynaecology clinic with a 6-month history of mixed stress and urge incontinence.
M, Basu, J R A, Duckett
openaire   +2 more sources

Third‐Line Overactive Bladder Treatments: Cost–Benefit Analysis in an Australian Public Hospital

ANZ Journal of Surgery, EarlyView.
ABSTRACT Introduction and Objectives To review the efficacy and cost‐effectiveness of third‐line overactive bladder (OAB) managements, including percutaneous tibial nerve stimulation (PTNS), intravesical botulinum toxin A (Botox) and sacral neuromodulation (SNM) in the urology department of a tertiary public hospital.
Rowan Klein Nulend, Marco Rosario, Dale Wood, Lawrence Kim, Audrey Wang   +4 more
wiley   +1 more source

Alkalinised lidocaine as an anaesthetic before onabotulinumtoxinA injections. a randomised trial

BJU International, Volume 135, Issue 4, Page 638-647, April 2025.
Objectives To evaluate the effect of intravesical alkalinised lidocaine as an anaesthetic treatment on procedural pain during intradetrusor onabotulinumtoxinA (BTX‐A) injections for overactive bladder. Patients and Methods This single‐centre, randomised, double‐blind, placebo‐controlled two period crossover trial was conducted on women scheduled for ...
Meryam El Issaoui, Marlene Elmelund, Niels Klarskov   +2 more
wiley   +1 more source

β3‐Adrenoceptor Agonists for Neurogenic Lower Urinary Tract Dysfunction: Evidence and Clinical Rationale for First‐Line Therapy

Neurourology and Urodynamics, Volume 45, Issue 8, Page 1476-1478, November 2026.
ABSTRACT Aims To summarize current evidence on β3‐adrenoceptor agonists for managing neurogenic lower urinary tract dysfunction (NLUTD), focusing on their efficacy, safety, and clinical role in optimizing bladder storage and protecting upper tracts. Methods Evidence from randomized controlled trials, meta‐analyses, and observational studies in spinal ...
Sharon E. Fishberg, Rano Matta
wiley   +1 more source

Botulinum Toxin A for Idiopathic Detrusor Overactivity

Annals of the Academy of Medicine, Singapore, 2010
Introduction: This prospective study aims to evaluate botulinum toxin type A (BTX-A, Botox®) as a treatment for idiopathic detrusor overactivity (IDO) for patients with symptoms of overactive bladder (OAB). Materials and Methods: Nineteen patients with IDO were treated with intradetrusal injection of 200 units of BTX-A under cystoscopic guidance. There
Kwok Ying, Lie, Michael Y C, Wong, Lay Guat, Ng   +2 more
openaire   +2 more sources

“What Medical Management Should Be First Line for Bladder Storage Symptoms in NLUTD”—Pro Botox

Neurourology and Urodynamics, Volume 45, Issue 8, Page 1479-1481, November 2026.
ABSTRACT Objectives Neurogenic lower urinary tract dysfunction (NLUTD) severely impairs patient quality of life (QoL). While oral medications are often first‐line treatments, their high failure rates and side effects limit their effectiveness. Thus, we argue for the use of intravesical botulinum toxin A (BoNT‐A) injections as a first‐line alternative ...
Vada Furlan, Alyssa Kobayashi, Zhina Sadeghi   +2 more
wiley   +1 more source

Treatment of neurogenic detrusor overactivity using botulinum toxin A [PDF]

, 2012
2. Summary Treatment of neurogenic detrusor overactivity using botulinum toxin A Introduction: The treatment of neurogenic detrusor overactivity (NDO) is still a serious medical, social and economic problem. Using onabotulinumtoxinA (onaBTA) is the first
Šámal, Vladimír
core  

Are there different patterns of detrusor overactivity which are clinically relevant? ICI-RS 2018

, 2019
Introduction: Different patterns of detrusor overactivity (DO) have been described and included in several standardization terminology documents. However, it is unclear if these different patterns have any clinical significance.Methods: This is a report ...
Valentini, Francoise, De Wachter, Stefan, Jerzy B. Gajewski, Cees Korstanje, DeWachter, S., Francoise Valentini, Valentini, F., Rahnama'i, Sajjad, Kirschner-Hermanns, R., Gammie, Andrew, Speich, J., Schurch, B., John Speich, Stefan De Wachter, Andrew Gammie, Schurch, Brigitte, Korstanje, Cees, Gajewski, Jerzy B., Kirschner-Hermanns, Ruth, Rahnama'i, M.S., Gajewski, J.B., Brigitte Schurch, Speich, John, Korstanje, C., Gammie, A., Mohammad Sajjad Rahnama’i, De Wachter, S., Ruth Kirschner‐Hermanns, Rahnama'i, Mohammad Sajjad   +28 more
core   +2 more sources

Urodynamic evaluation of neurogenic lower urinary tract dysfunction in children with Guillain-Barre syndrome within 6 months

Frontiers in Neurology
ObjectiveThis study aimed to evaluate urodynamic characteristics, identify high-risk and unfavorable urodynamic findings in children with neurogenic lower urinary tract dysfunction (NLUTD) secondary to Guillain-Barre syndrome (GBS) within 6 months since ...
Yan Long, Yan Long, Hui Zhang, Hui Zhang, Naixi Zhang   +4 more
doaj   +1 more source

Utility of Pelvic Floor Therapy and Behavioral Interventions in the Neurogenic Lower Urinary Tract Dysfunction (NLUTD) Population

Neurourology and Urodynamics, Volume 45, Issue 8, Page 1493-1499, November 2026.
ABSTRACT Aims Neurogenic lower urinary tract dysfunction (NLUTD) describes a wide range of symptoms depending on neurologic diagnosis and the resulting bladder and sphincter dysfunction. This narrative review is designed to address the question regarding which NLUTD population benefits most from pelvic floor therapy and behavioral interventions, and ...
Sara M. Lenherr
wiley   +1 more source